Connect with us

Health

Audit exposes weak monitoring and funding doubts in EU cancer strategy

SHARE:

Published

3 months ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The European Court of Auditors (ECA) has warned that Europe’s Beating Cancer Plan (EBCP) is “fraught with uncertainty”, according to an audit published on 19 February.

Launched in 2021 with an initial budget of €4 billion for the 2021–2027 period, the EBCP aims to tackle cancer across the entire disease pathway, from prevention and early detection to treatment, survivorship and patients’ quality of life.

Klaus-Heiner Lehne, the ECA member responsible for the audit, said the plan suffers from several structural shortcomings. Chief among them is the absence of a comprehensive monitoring framework. “Many objectives lack measurable targets, actions operate on different timelines, and there...

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter.

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending